Acorda and AstraZeneca claim victory over Mylan

21-03-2016

Acorda and AstraZeneca claim victory over Mylan

zimmytws / Shutterstock.com

The US Court of Appeals for the Federal Circuit has rejected Mylan’s attempt to dismiss two patent lawsuits on the grounds of lack of personal jurisdiction.


Acorda Therapeutics, Mylan, AstraZeneca, patent, FDA, generics, ANDA, US Court of Appeals for the Federal Circuit

LSIPR